CURIS

At Curis, we are developing differentiated therapeutics with the goal of improving the lives of cancer patients. Our new animation shows how Emavusertib (CA-4948) is being developed to target hematologic malignancies and other cancers... At Curis, we apply this meaning to cancer, by developing novel therapies for slowing or preventing the progression of cancer and prolonging life - or closing and curi͒ng cancer... We are a biotechnology company focused on the development of first-in-class and innovative therapeutics for the treatment of cancer.

Also known as: Curis, Inc.

Primary location: Lexington United States